4th Covalent Drug Discovery & Development Summit
Tuesday, October 20, 2026 - 8:00 AM
to Thursday, October 22, 2026 - 3:10 PM
8:00 AM - 3:10 PM See all dates and Times
Covalent drug discovery has entered a defining new phase where scientific validation is no longer the primary barrier; successful clinical translation now takes center stage.
Once limited by concerns around off-target toxicity, covalent approaches are now unlocking undruggable targets and expanding beyond oncology into new therapeutic areas. As next-generation warheads, chemoproteomics, and AI-driven design accelerate innovation, the key challenge is clear: how to translate covalent candidates into safe, effective clinical therapies.
The 4th Covalent Drug Discovery & Development Summit is the only industry forum dedicated to advancing covalent therapeutics end-to-end, from discovery through to IND and early clinical development.
Uniting experts from Bristol Myers Squibb, Novartis, Pfizer, Biogen, Nexo Therapeutics, and Frontier Medicines, this summit goes beyond high-level discussion to deliver data-driven case studies, translational strategies, and real clinical insights.
Join 80+ covalent leaders to:
De-risk your pipeline with early clinical and translational learnings
Overcome selectivity, safety, and PK/PD challenges
Gain candid insights not found in publications
As more covalent drugs enter the clinic, now is the time to turn promise into proof.
Event Links
Website: https://go.evvnt.com/3686853-0
Tickets: https://go.evvnt.com/3686853-2
Brochure: https://go.evvnt.com/3686853-3
